XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th Receivables

As of the most recent data (March 2026), XOMAO shows a receivables of $23M. That compares with $5.5M in the prior-year period — up 320.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XOMAO's receivables is now $23M (was $5.5M) — a 320.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th is outperforming or lagging.

Tracking XOMAO's receivables over time shows whether XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th is scaling, shrinking, or reshaping that part of the business. The current reading is $23M That compares with $5.5M in the prior-year period — up 320.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $23M) with ownership activity and broader fundamentals.

XOMA Royalty - 8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th's receivables is $23M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.